Novartis, Teva End Long-Running Lotrel Patent Suit
U.S. District Judge Garrett E. Brown Jr. signed off on the agreement, which resolves the case over Teva's generic version of Novartis' Lotrel. The parties settled two separate cases, each of which involve the same patent but different dosage strengths.
"Under the agreement, Teva admits to the validity of the Novartis patents and that they have...
Already a subscriber? Click here to login